NewAmsterdam Pharma Company N.V. (NAMS)

Last Closing Price: 20.21 (2025-06-13)

End Cash (Quarterly)

End Cash: The amount of cash held by the company for the given period.

NewAmsterdam Pharma Company N.V. (NAMS) had End Cash of $748.42M for the most recently reported fiscal quarter, ending 2025-03-31.

Figures for fiscal quarter ending 2025-03-31
Income Statement Financials
$2.98M
$-39.53M
--
$2.98M
$71.90M
$-68.92M
$29.40M
$-39.53M
$-39.53M
$-39.53M
$-39.53M
$-39.53M
$-39.53M
$-68.92M
$-68.87M
116.12M
116.12M
$-0.34
$-0.34
Balance Sheet Financials
$817.30M
$0.24M
$1.11M
$818.41M
$40.91M
--
$0.14M
$41.05M
$777.36M
$776.86M
$777.36M
112.17M
Cash Flow Statement Financials
$-36.47M
$2.85M
$6.52M
$771.74M
End Cash
$748.42M
$-23.32M
$15.21M
--
--
Fundamental Metrics & Ratios
19.98
--
--
--
--
100.00%
-2314.47%
-2314.47%
--
-1327.30%
-1327.30%
$-36.48M
--
--
--
0.00
--
--
--
-5.08%
-5.09%
-4.83%
-5.08%
$6.93
$-0.31
$-0.31